Upgrade to SI Premium - Free Trial

RBC Capital Reiterates Sector Perform Rating on Regeneron Pharma (REGN)

September 1, 2026 8:56 AM
RBC Capital analyst Brian Abrahams reiterated a Sector Perform rating and $737.00 price target on Regeneron Pharma (NASDAQ: REGN).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments